title: [Anti-U1RNP antibodies and lupus nephritis].
abstract: BACKGROUND
  Systemic Lupus Erythematosus is characterized by production of numerous autoantibodies as an abnormal immune response. The most important antibodies are those aimed at constitutive elements of cell nucleus.
  
  
  METHODS
  After antigen typing of antinuclear antibodies in 30 patients with Systemic Lupus Erythematosus we analyzed the correlation between anti-Sm antibodies and anti-U1RNP antibodies and the degree of disease activity, such as correlation of these two antibodies with some clinical manifestations of this disease. This study included patients who fulfilled all revised American Rheumatism Association criteria to diagnose systemic lupus. To determine the degree of disease activity we used Systemic Lupus Erythematosus Disease Activity Index after Bombardier. To detect antinuclear antibodies technique of indirect immunofluorescence and ELISA procedure for antigen typing of these antibodies were used.
  
  
  RESULTS
  We registered antinuclear antibodies (ANA) in 100% of our patients, with domination of homogenous pattern of immunofluorescence (70%). Speakled pattern was registered in 16.66% and margin type in 6.66%. Using ELISA procedure of antigen typing of ANA we registered anti-U1RNP antibodies in 26.7% patients, while anti-Sm antibodies were registered in 20%.
  
  
  CONCLUSIONS
  Anti-U1RNP antibodies finding is associated with mild forms of disease and rare appearance of lupus nephritis, while anti-Sm antibodies finding is characteristic for very active forms of disease and often lupus nephritis.
authors.affiliation: Institut za interne bolesti, Klinika za nefrologiju i klinicku imunologiju, Medicinski fakultet, Novi Sad.
authors.forename: T
authors.initials: T
authors.lastname: Ilić
authors.forename: S
authors.initials: S
authors.lastname: Curić
authors.forename: S
authors.initials: S
authors.lastname: Vodopivec
authors.forename: I
authors.initials: I
authors.lastname: Mitić
authors.forename: T
authors.initials: T
authors.lastname: Durdević-Mirković
authors.forename: V
authors.initials: V
authors.lastname: Sakac
authors.forename: P
authors.initials: P
authors.lastname: Lenert
mesh_terms: D000293:Adolescent; D000328:Adult; D000974:Antibodies, Antinuclear / Q000032:analysis*; D001324:Autoantigens / Q000276:immunology; D002648:Child; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000276:immunology; D008181:Lupus Nephritis / Q000175:diagnosis / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D017412:Ribonucleoprotein, U1 Small Nuclear / Q000276:immunology*; D017411:Ribonucleoproteins, Small Nuclear; D055517:snRNP Core Proteins
chemical_list: D000974:Antibodies, Antinuclear; D001324:Autoantigens; D017412:Ribonucleoprotein, U1 Small Nuclear; D017411:Ribonucleoproteins, Small Nuclear; D055517:snRNP Core Proteins